In metastatic tumors found in lymph node and drug-resistant cancers of several origins, an increased TG2 level is associated with acquisition of epithelial–mesenchymal transition and stem cell–like characteristics, traits that require changes in gene expression (Kumar et al, 2010, 2011). This evidence concerns the gene TGM2 and metastatic neoplasm.